Israel - English - Ministry of Health

propharm ltd - baclofen - solution for injection - baclofen 10 mg / 5 ml - baclofen - baclofene bioindustria l.i.m. 10mg/5ml is indicated in patients with severe chronic spasticity resulting from trauma, multiple sclerosis or other spinal cord disorders, who are unresponsive to oral baclofen or other orally administered antispastic agents and/or those patients who experience unacceptable side effects at effective oral doses.baclofene bioindustria l.i.m. 10mg/5ml is effective in adult patients with severe chronic spasticity of cerebral origin, resulting e.g. from cerebral palsy, brain trauma or cerebrovascular accident; however, clinical experience is limited.pediatric population:baclofene bioindustria l.i.m. 10mg/5ml is indicated in patients aged 4 to <18 years with severe chronic spasticity of cerebral origin or of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

Malta - English - Medicines Authority

bioindustria laboratorioitaliano medicinali via de ambrosiis 2, novi ligure (al), 15067, italy - baclofen - solution for injection - baclofen 10 mg/5ml - muscle relaxants

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

neo life medicine store l.l.c italy - 5 ml x 5 glass ampoules - injection - 10 mg/5 ml - musculoskeletal ,joint diseases-neuromuscular disorders

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

neo life medicine store l.l.c italy - 1 ml x 10 glass ampoules - injection - 0.05 mg/ml - musculoskeletal ,joint diseases-neuromuscular disorders

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

neo life medicine store l.l.c italy - 20 ml x 1 glass ampoule - injection - 10 mg/20 ml - musculoskeletal ,joint diseases-neuromuscular disorders

Israel - English - Ministry of Health

dexcel pharma technologies ltd - losartan potassium - tablets - losartan potassium 12.5 mg - losartan - losartan - heart failure: losardex 12.5 mg is indicated for the treatment of heart failure, when treatment with an ace inhibitor is no longer considered appropriate. switching patients with heart failure who are stable on an ace inhibitor to losardex 12.5 mg is not recommended.

Israel - English - Ministry of Health

dexcel pharma technologies ltd - losartan potassium - tablets - losartan potassium 50 mg - losartan - losartan - hypertension: losardex 50 is indicated for the treatment of hypertensionheart failure: losardex 50 is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ace inhibitor is not appropriate.switching patients with heart failure who are stable on an ace inhibitor to losardex 50 is not recommended.renal protection in type-2 diabetic patients with proteinuria: losardex 50 is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex 50 is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.the benefit of losardex 50 on the primary deposite endpoint was largely driven by reduction in the risk of stroke.

Israel - English - Ministry of Health

dexcel pharma technologies ltd - losartan potassium - tablets - losartan potassium 50 mg - losartan - losartan - hypertension: losardex 50 is indicated for the treatment of hypertensionheart failure: losardex 50 is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ace inhibitor is not appropriate.switching patients with heart failure who are stable on an ace inhibitor to losardex 50 is not recommended.renal protection in type-2 diabetic patients with proteinuria: losardex 50 is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex 50 is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.the benefit of losardex 50 on the primary deposite endpoint was largely driven by reduction in the risk of stroke.

Israel - English - Ministry of Health

dexcel pharma technologies ltd - losartan potassium - caplets - losartan potassium 100 mg - losartan - losartan - hypertension: losardex 100 is indicated for the treatment of hypertensionheart failure: losardex 100 is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ace inhibitor is not appropriate.switching patients with heart failure who are stable on an ace inhibitor to losardex 100 is not recommended.renal protection in type-2 diabetic patients with proteinuria: losardex 100 is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex 100 is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.the benefit of losardex 100 on the primary deposite endpoint was largely driven by reduction in the risk of stroke.

Israel - English - Ministry of Health

dexcel pharma technologies ltd - losartan potassium - caplets - losartan potassium 100 mg - losartan - losartan - hypertension: losardex 100 is indicated for the treatment of hypertensionheart failure: losardex 100 is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ace inhibitor is not appropriate.switching patients with heart failure who are stable on an ace inhibitor to losardex 100 is not recommended.renal protection in type-2 diabetic patients with proteinuria: losardex 100 is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex 100 is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.the benefit of losardex 100 on the primary deposite endpoint was largely driven by reduction in the risk of stroke.